Pfizer Covid jab approved for use in some five to 11-year-olds

A new formulation of the Pfizer/BioNTech coronavirus vaccine has been approved for use in children aged five to 11. The UK’s Medicines and Healthcare products Regulatory Agency made the approval following a robust review of safety data that shows a positive benefit-risk profile for this jab to be used in the age group. In light of the regulator’s approval, the Joint Committee on Vaccination and Immunisation is advising that children aged five to 11, who are in a clinical risk group, or who are a household contact of someone (of any age) who is immunosuppressed, should be offered a primary course of vaccination.